CAMBRIDGE, Mass., May 1, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call onTuesday, May 8, 2018, at 4:30 p.m. ET to review its first quarter 2018 financial results and provide an update on the company.
A live webcast of the conference call can be accessed
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:Stephanie Ascher, Stern Investor Relations, Inc.212-362-1200 or Stephanie@sternir.com
View original content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-first-quarter-2018-financial-results-conference-call-and-webcast-300640374.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Tularemia is an uncommon, highly contagious bacterial infection acquired in humans by insect bites ...
Nipah Virus (NiV) or Hendra virus is a deadly virus that spreads via contact with the saliva, ...
Nose Bleeds or Epistaxis are common during summer. Here are simple tips to prevent nasal bleeding ...View All